IndraLab

Statements

P5091 activates CCDC6. 1 / 1

| 1

reach

"Notably, by adding back ectopic wt CCDC6 plasmid to the LNCaP treated with P5091, we were able to rescue the weak sensitivity to olaparib, in terms of 50% inhibitor concentration values (IC50) (XREF_SUPPLEMENTARY), suggesting a pivotal role of CCDC6 as a USP7 substrate."

28415632

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 activates CCDC6. 1 / 1

INDRA sources:

Databases

Reading